The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

A research team at The University of Osaka revealed that the loss of heterochromatin can cause a chain reaction leading to ...

Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...

CSIC, reveals how the bacterium that causes cholera activates its virulence programme, uncovering a single amino acid as a ...

Accomplished RNA therapeutics leader with track record of advancing novel genetic medicines from discovery to FDA approval to ...

Gertrude B. Elion, a chemist working in the research laboratories of Burroughs Wellcome, revolutionized childhood cancer ...

Codexis expands reach of the ECO Synthesis Manufacturing Platform through a signed evaluation agreement with Axolabs for oligonucleotide therapeutics: Redwood City, California Mon ...

The first line of treatment for cancer is, whenever possible, to remove the cancerous tissue from the body. Though often ...